3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Phase 1
1
Status
Completed
6
Unknown
3
Recruiting
2
Terminated
1
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
2
Other solid neoplasm
1
Conditions
Prostatic Neoplasms
965
Urinary Bladder Neoplasms
268
Carcinoma, Renal Cell
253
Kidney Neoplasms
146
Breast Neoplasms
131
Carcinoma, Transitional Cell
127
Neoplasms
122
Colorectal Neoplasms
100
Ovarian Neoplasms
93
Melanoma
85
Carcinoma, Non-Small-Cell Lung
84
Lung Neoplasms
83
Neoplasm Metastasis
79
Pancreatic Neoplasms
69
Non-Muscle Invasive Bladder Neoplasms
68
Uterine Cervical Neoplasms
59
Stomach Neoplasms
56
Head and Neck Neoplasms
52
Endometrial Neoplasms
50
Squamous Cell Carcinoma of Head and Neck
48
Esophageal Neoplasms
44
Adenocarcinoma
44
Testicular Neoplasms
42
Carcinoma, Hepatocellular
41
Sarcoma
39
Triple Negative Breast Neoplasms
34
Liver Neoplasms
32
Disease
31
Colonic Neoplasms
29
Metastatic Castration-resistant Prostate Cancer
25
Interventions
Sirolimus
1
Nelfinavir
1
Metformin
1
Hydroxychloroquine
1
Dasatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Prostate Cancer Recurrent
×
Genitourinary
×
Clear all
NCT05036226
2026-05-13
COAST
Medical University of South Carolina
Phase 1/2
Recruiting
76 enrolled
NCT05646550
2024-05-16
ProSperACC-1
University Hospital Tuebingen
Phase 1
Recruiting
56 enrolled